"This practice has been adopted by multiple organ-procurement organizations and is used on thousands of organ donors each year, without ever having been rigorously studied," one researcher said. 

GLP-1 agonists are often taken as daily or weekly injections. A new delivery system could help make it so those same drugs are only required three times per year. 

The FDA considers this a Class I recall, which means using the impacted devices “may cause serious injuries or death.” One patient injury has been reported at this time. 

Following the popular Mediterranean diet instead of a “Western” diet can be quite beneficial for women in their forties and fifties, researchers confirmed. 

"Although the effectiveness of ADHD medications has been demonstrated ... concerns remain regarding their potential cardiovascular safety," one research explained. 

Even patients with no symptoms may be at risk, according to new findings published in the Journal of Allergy and Clinical Immunology.

This is the second time in a matter of weeks the FDA has approved an RDN system for uncontrolled hypertension. The SCAI issued a statement about this trend, calling it a “game-changer for both interventional cardiology and the treatment of hypertension."

While the therapy has been successfully tested on animals in the past, this study represents the first time it has been used on humans.